Expanded Discovery Allowed In Actavis Digitek MDL

Law360, New York (July 2, 2009, 12:00 AM EDT) -- A federal judge has allowed for expanded discovery and has refused Actavis Group's bid to quash a subpoena in the multidistrict product liability case accusing Actavis of selling a defective or adulterated heart medication.

Judge Mary E. Stanley's pretrial discovery ruling, issued Wednesday in the U.S. District Court for the Southern District of West Virginia, stopped short of allowing the plaintiffs to investigate all of the product lines that were made at the Little Falls, N.J., plant where plaintiffs claim the defective Digitek medication was produced....
To view the full article, register now.